期刊文献+

流感病毒对两种细胞敏感性的比较 被引量:17

COMPARISON OF THE SENSITIVITY OF VERO CELL AND MDCK CELL TO INFLUENZA VIRUS
在线阅读 下载PDF
导出
摘要 目的比较流感病毒对Vero细胞和MDCK细胞敏感性的差异及影响敏感性的因素,寻找流感病毒灭活试验的最佳细胞。方法用测定两种细胞感染病毒后TCID50值和血凝效价值的方法,了解流感病毒对两种细胞敏感性的差异。结果Vero细胞和MDCK细胞接种流感病毒72 h,测得血凝效价分别为1:64和1:128;MDCK细胞的病变较Vero细胞明显。终浓度为5μg/ml的胰酶可提高两种细胞增殖流感病毒的血凝效价,但对TCID50值的大小无明显的影响。随着维持液中血清浓度的升高,两种细胞增殖病毒的血凝效价逐渐降低,MDCK细胞染毒后的TCID50值也明显减小。结论流感病毒对MDCK细胞的敏感性高于对Vero细胞的敏感性,胰酶和血清能影响病毒对细胞的敏感性。 Objective To compare the sensitivity of Vero cell and MDCK cell to influenza virus and the factors in fluencing the sensitivity and to find the suitable cell for use in influenza virus inactivation test. Methods TCID50 test and hemagglutinatian test were used for comparing the sensitivity of the two kinds of cells to influenza virus. Results At 72 h after inoculation of influenza virus, the titers of hemagglutination in Vera cells and MDCK cells were 1:64 and 1:128 respectively. The cytopathic effect on MDCK cells was more obvious than on Vero cells. Pancreatin at the concentration of 5μg/ml increased the titers of hemagglutination of the two kinds of cells to influenza virus, but had no effect on TCID50. Increase in sera in the maintenance media decreased the titers of hemagglutination of the two kinds of cells to influenza virus, and the value of TCIDs0 of MDCK cells to influenza viruses. Conclusion The sensitivity of MDCK cell was higher than that of Vero cell. Furthermore, pancreatin and sera could influence the sensitivity of two kinds of cells to influenza virus.
出处 《中国消毒学杂志》 CAS 北大核心 2008年第5期463-465,共3页 Chinese Journal of Disinfection
关键词 流感病毒 VERO细胞 MDCK细胞 敏感性 血凝效价 细胞病变 influenza virus Vero cell MDCK cell sensitivity titer of hemagglutination cytopathy
作者简介 赵斌秀(1966-),女,河北行唐人,大学本科,副主任技师,主要从事消毒研究工作。 [通讯作者]李新武,lxwcdd@sina.com。
  • 相关文献

参考文献5

二级参考文献56

  • 1张华捷,张庶民.流感疫苗[J].国外医学(预防.诊断.治疗用生物制品分册),2004,27(4):145-147. 被引量:1
  • 2李仁清,阮力.流感疫苗研究进展[J].中华实验和临床病毒学杂志,2004,18(2):198-200. 被引量:4
  • 3刘华雷,魏建超,周斌,曹瑞兵,陈溥言.禽流感病毒血凝素基因突变体的构建及其在293T细胞中的表达[J].微生物学报,2005,45(4):614-616. 被引量:4
  • 4张效群.细胞培养物作为生产流感疫苗的基质[J].国外医学(预防.诊断.治疗用生物制品分册),1996,19(5):208-211. 被引量:1
  • 5Seo S H,Hoffmann E,Webster R G.Lethal H5N1 influenza viruses escape host anti-viral cytokine responses[J].Nat Med,2002,8:950-954.
  • 6Maassab H F,DeBorde D C.Characterization of an influenza A host range mutant[J].Virology,1983,130:342-350.
  • 7Snyder M H,London W T,Maassab H F,et al.A 36 nucleotide deletion mutation in the coding region of the NS1 gene of an influenza A virus RNA segment 8 specifies a temperature-dependent host range phenotype[J].Virus Res,1990,15:69-83.
  • 8Bruhl P,Kerschbaum A,Kistner O,et al.Humoral and cell-mediated immunity to Vero cell-derived influenza vaccine[J].Vaccine,2000,19:1149-1158.
  • 9Kida H,Brown L E,Webster R G.Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus[J].Virology,1982,122:38-47.
  • 10Fortes P,Beloso A,Ortin J.Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport[J].EMBO J,1994,13:704-712.

共引文献31

同被引文献141

引证文献17

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部